ArticleCell death & disease2014

SKLB-163, a new benzothiazole-2-thiol derivative, exhibits potent anticancer activity by affecting RhoGDI/JNK-1 signaling pathway.

X Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.